Adaptive ABAB Design — Adaptive Reversal Design
Adaptive ABAB Reversal Design · Also known as: adaptive reversal design, adaptive single-subject ABAB, ABAB with adaptive phase-change rules, dynamic ABAB design
The Adaptive ABAB Design is a single-subject experimental methodology that extends the classic ABAB reversal design by incorporating data-driven, prospective decision rules to determine when to transition between baseline (A) and intervention (B) phases. Rather than fixing phase lengths in advance, the researcher uses pre-specified criteria — such as stability thresholds, slope targets, or effect-size benchmarks — to guide each phase change, improving both experimental control and clinical responsiveness.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use the Adaptive ABAB Design when you are studying a reversible behavior or outcome in a single participant (or a small series of replicated individuals), when you want the stringent causal inference of a reversal design but need phase lengths to respond to actual data rather than an arbitrary calendar, and when clinical or ethical concerns require that interventions be extended or withdrawn only when the data warrant it. It is particularly well-suited to applied behavior analysis, clinical psychology, and special education research where individual response variability is high. Do not use this design for outcomes that are irreversible once learned (e.g., academic skills that cannot be unlearned on withdrawal), for situations where withdrawal of an effective treatment would be clinically unethical, or when continuous repeated measurement of the outcome is not feasible.
Strengths & limitations
- Provides rigorous within-person experimental control: replication of effect across B1 and B2 phases supports causal inference without a control group.
- Adaptive phase-change rules reduce the risk of making phase transitions based on insufficient or misleading data, improving internal validity.
- Clinically responsive — participants who respond faster advance sooner, and those who respond more slowly are not prematurely moved forward.
- Pre-specified criteria make the decision process transparent and reproducible, reducing researcher degrees of freedom.
- Suitable for low-incidence populations where randomized controlled trial sample sizes are not attainable.
- Requires a reversible target behavior — if the behavior or skill does not return toward baseline upon withdrawal, the experimental logic breaks down.
- Withdrawal of an effective treatment in A2 raises ethical questions in applied clinical contexts, which must be addressed in the study protocol.
- Results apply definitively to the individual studied; replication across participants is needed before generalizing findings.
- Developing principled, pre-specified phase-change criteria demands expertise and pilot data; poorly chosen thresholds can produce uninformative phase sequences.
- Sequential phase structure means the study can extend considerably if a participant is slow to meet stability or response criteria.
Frequently asked
How is the Adaptive ABAB design different from a standard ABAB design?
In a standard ABAB design the length of each phase is fixed in advance by the researcher. In the Adaptive ABAB design, pre-specified data-based criteria — such as stability thresholds or minimum effect benchmarks — determine when each phase ends and the next begins. This means phase transitions are earned by the data rather than imposed by a predetermined schedule, which improves internal validity and clinical responsiveness.
What stability criteria are commonly used to trigger a phase change?
The most common approach requires a minimum number of consecutive data points (typically five to eight) that fall within a defined variability band (e.g., all points within ±20% of the phase mean) and show no systematic trend. Other researchers use trend-line slope thresholds, or non-overlap statistics such as Tau-U or the Percentage of Non-overlapping Data (PND) to judge whether a sufficient treatment response has been reached in an intervention phase.
Is it ethical to withdraw an effective treatment in the A2 phase?
This is a genuine ethical tension in all reversal designs. Common safeguards include limiting withdrawal duration, using only brief or partial withdrawals, restoring the intervention at the first sign of clinically significant deterioration, and obtaining informed consent specifically for the withdrawal component. The adaptive design mitigates some of this concern by ensuring withdrawal ends as soon as the data demonstrate return toward baseline — rather than after a fixed number of sessions.
How many participants do I need?
The Adaptive ABAB is fundamentally a single-subject design — even one participant can yield valid causal evidence if the within-person replication across B1 and B2 is clear. Replicating the study across three to five additional participants, however, substantially strengthens external validity and is recommended by most single-case research guidelines.
Can I pre-register an Adaptive ABAB study?
Yes, and pre-registration is strongly encouraged. The phase-change criteria — stability definitions, consecutive-session windows, effect thresholds, and any stopping rules — should be documented and time-stamped before data collection. Registries such as OSF or ClinicalTrials.gov accept single-subject study protocols.
Sources
- Barlow, D. H., & Hersen, M. (1984). Single Case Experimental Designs: Strategies for Studying Behavior Change (2nd ed.). Pergamon Press. ISBN: 978-0205143641
- Normand, M. P., & Bailey, J. S. (2006). The human right to effective behavioral treatment. The Behavior Analyst, 29(2), 253–261. link ↗
How to cite this page
ScholarGate. (2026, June 3). Adaptive ABAB Reversal Design. ScholarGate. https://scholargate.app/en/experimental-design/adaptive-abab-design
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- Alternating Treatments DesignDisability Studies↔ compare
- Changing Criterion DesignDisability Studies↔ compare
- Interrupted Time SeriesCausal inference↔ compare
- Multiple Baseline DesignExperimental design↔ compare